Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2015 Nov 25;77(1):181–193. doi: 10.1007/s00280-015-2907-4

Fig. 1.

Fig. 1

Schematic of the PD model for combination effects of gemcitabine (Gem) and trabectedin (Et743) on pancreatic cancer cells. Definitions of parameters for the model and Eq. (4) are listed in Table 3. Solid lines with arrows indicate turnover of the indicated response. Dashed lines ending in closed circles indicate that an effect is being exerted by the connected factors.